Archives: Speakers

David is bringing over 20 years of comprehensive experience in the CRO sector, partnering with biotech, pharmaceutical, and life science organisations. Known for influencing critical business inflection drivers, developing robust clinical development strategies, and creating alignment across complex stakeholder ecosystems spanning sponsors and service providers

Lars Müller has been an entrepreneur since the age of 15 and is currently one of the youngest CEOs of a publicly traded cannabis company. With SynBiotic SE, he is building a European platform to drive the research and development of new cannabinoid and terpene-based solutions to major societal problems such as pain, sleep and anxiety.

Tatiana Eidus received her Master’s Degree in Biophysics from Moscow State University. Entering the industry more than a decade ago, Tatiana has accumulated wide expertise in all the operational aspects of initiating and managing Phase I-III trials across Europe and US. Prior to joining ARENSIA Exploratory Medicine, Tatiana worked for GSK and Merck. Primarily focused on early-stage exploratory programs, she conducted trials in various disease areas. In her current role as Director Corporate Development, Tatiana supports ARENSIA’s partners in the US, supervising cross-functional coordination throughout study planning, start-up and execution.